Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146


First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

Ishihara M, Tono Y, Miyahara Y, Muraoka D, Harada N, Kageyama S, Sasaki T, Hori Y, Soga N, Uchida K, Shiraishi T, Sato E, Kanda H, Mizuno T, Webster GA, Ikeda H, Katayama N, Sugimura Y, Shiku H.

Cancer Immunol Immunother. 2020 Apr;69(4):663-675. doi: 10.1007/s00262-020-02483-1. Epub 2020 Jan 24.


Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure.

Kajiwara S, Ishii K, Sasaki T, Kato M, Nishikawa K, Kanda H, Arima K, Watanabe M, Sugimura Y.

Lab Invest. 2019 Dec 19. doi: 10.1038/s41374-019-0352-4. [Epub ahead of print]


Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration.

Ishii K, Matsuoka I, Sasaki T, Nishikawa K, Kanda H, Imai H, Hirokawa Y, Iguchi K, Arima K, Sugimura Y.

J Clin Med. 2019 Sep 3;8(9). pii: E1379. doi: 10.3390/jcm8091379.


Successfully Treated Lung and Renal Metastases from Primary Chondrosarcoma of the Scapula with Radiofrequency Ablation and Surgical Resection.

Sekito S, Kato M, Nishikawa K, Yoshio Y, Kanai M, Kanda H, Arima K, Sugimura Y.

Case Rep Oncol Med. 2019 Jun 9;2019:6475356. doi: 10.1155/2019/6475356. eCollection 2019.


The usefulness of the maximum Hounsfield units (HU) in predicting the shockwave lithotripsy outcome for ureteral stones and the proposal of novel indicators using the maximum HU.

Sugino Y, Kato T, Furuya S, Sasaki T, Arima K, Sugimura Y.

Urolithiasis. 2020 Feb;48(1):85-91. doi: 10.1007/s00240-019-01123-3. Epub 2019 Mar 11.


Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T; KEYNOTE-426 Investigators.

N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16.


Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G₁ Cell Cycle Arrest.

Ishii K, Sasaki T, Iguchi K, Kato M, Kanda H, Hirokawa Y, Arima K, Watanabe M, Sugimura Y.

J Clin Med. 2019 Jan 4;8(1). pii: E44. doi: 10.3390/jcm8010044.


Tyrosine kinase inhibitor therapy prescribed for non-urologic diseases can modify PSA titers in urology patients.

Sasaki T, Franco OE, Ohishi K, Filipovich Y, Ishii K, Crawford SE, Takahashi N, Katayama N, Sugimura Y, Hayward SW.

Prostate. 2019 Feb;79(3):259-264. doi: 10.1002/pros.23730. Epub 2018 Oct 28.


Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme.

Miki M, Ishii K, Sasaki T, Kato M, Kajiwara S, Kanda H, Arima K, Hirokawa Y, Watanabe M, Sugimura Y.

Urol Oncol. 2018 Oct;36(10):472.e1-472.e9. doi: 10.1016/j.urolonc.2018.07.008. Epub 2018 Aug 20.


Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation.

Ishii K, Sasaki T, Iguchi K, Kajiwara S, Kato M, Kanda H, Hirokawa Y, Arima K, Mizokami A, Sugimura Y.

Prostate. 2018 Aug;78(11):849-856. doi: 10.1002/pros.23643. Epub 2018 Apr 29.


Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate.

Ishii K, Takahashi S, Sugimura Y, Watanabe M.

J Clin Med. 2018 Apr 2;7(4). pii: E68. doi: 10.3390/jcm7040068. Review.


Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.

Ishii K, Matsuoka I, Kajiwara S, Sasaki T, Miki M, Kato M, Kanda H, Arima K, Shiraishi T, Sugimura Y.

J Cancer Res Clin Oncol. 2018 Jan;144(1):89-98. doi: 10.1007/s00432-017-2536-x. Epub 2017 Nov 2.


Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus.

Enokiya T, Nishikawa K, Muraki Y, Iwamoto T, Kanda H, Sugimura Y, Okuda M.

J Pharm Health Care Sci. 2017 Jun 24;3:17. doi: 10.1186/s40780-017-0086-7. eCollection 2017.


Ablation therapy for renal cell cancer of elderly patients.

Kanda H, Arima K, Sugimura Y.

Nihon Rinsho. 2017 Apr;75(4):597-601. Japanese.


Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells.

Iwamoto Y, Ishii K, Kanda H, Kato M, Miki M, Kajiwara S, Arima K, Shiraishi T, Sugimura Y.

J Cancer Res Clin Oncol. 2017 Jun;143(6):933-939. doi: 10.1007/s00432-017-2367-9. Epub 2017 Feb 27.


Successful Preservation of the Bladder in a Case of Inflammatory Myofibroblastic Tumor with the Diagnostic Efficacy of ALK/p80 Immunohistochemistry and FISH Analysis: Case Report and Review of the Literature.

Kato M, Masui S, Kanda H, Arima K, Shiraishi T, Sugimura Y.

Urol Case Rep. 2017 Jan 5;11:19-21. doi: 10.1016/j.eucr.2016.11.018. eCollection 2017 Feb.


Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study.

Mizuno K, Inoue T, Kinoshita H, Yano T, Kawanishi H, Kanda H, Terada N, Kobayashi T, Kamba T, Mikami Y, Shiraishi T, Uemura Y, Imai Y, Honjo G, Shirase T, Okumura K, Kawakita M, Ogura K, Sugimura Y, Matsuda T, Ogawa O.

Jpn J Clin Oncol. 2016 Dec;46(12):1156-1161. Epub 2016 Oct 15.


Photoselective Vaporization of the Prostate: Long-Term Outcomes and Safety During 10 Years of Follow-Up.

Yamada Y, Furusawa J, Sugimura Y, Kuromatsu I.

J Endourol. 2016 Dec;30(12):1306-1311.


[A Case of Emphysematous Cystitis with Bladder Diverticulum].

Kajiwara S, Matsuura H, Arase S, Hori Y, Tochigi H, Sugimura Y.

Hinyokika Kiyo. 2016 Aug;62(8):431-3. doi: 10.14989/ActaUrolJap_62_8_431. Japanese.

Supplemental Content

Loading ...
Support Center